Genvax is a startup animal vaccine company located in Ames, Iowa. We have a dynamic team of experienced scientists and entrepreneurs poised to develop next generation RNA + nanoparticle vaccines for animal health. This isn’t the first go-around for co-founders Joel Harris and Dr. Hank Harris, who successfully created, grew and sold Harrisvaccines to Merck Animal Health in 2015. Our Mission: Genvax Technologies accelerates breakthrough solutions to the animal health industry. We commercialize the tools for livestock producers and veterinarians that no one else can. Our Vision: We believe in rapidly responding to the world around us. We cultivate new ideas to develop novel solutions and create a long-lasting impact on animal health world-wide.
| Website | http://www.genvax.com |
| Employees | 8 (6 on RocketReach) |
| Founded | 2021 |
| Address | 2503 S Loop Dr STE 5446, Ames, Iowa 50010, US |
| Phone | +1 740-369-8981 |
| Industry | Biotechnology |
| Keywords | Animal Health, Animal Vaccines, Veterinary Vaccines, Veterinary Medicine, Rna Vaccines, Animal Therapeutics, Vaccine Technology, Vaccine Development, Livestock Vaccines, Pet Vaccines, Vaccine Research, Next Generation Vaccines, Rna Technology, Nanoparticle Technology, Biotechnology, Immunotherapy, Drug Delivery, Pharmaceutical, Biopharma |
| Competitors | Moderna Therapeutics, Pfizer, CureVac, Novavax, Sanofi, GSK, Johnson & Johnson, Roche, Merck & Co., Inc., AstraZeneca +45 more (view full list) |
Looking for a particular Genvax employee's phone or email?